...Abgenix Inc. up $3.00 at $17.70 Investors interpreted the good news for Tarceva as boosting prospects for this biotech's own cancer drug. Abatix Corp. down $1.55 at $7.23 A shareholder lawsuit was announced late Friday against the company...
If you are the owner of this website, please log in for additional
information or contact us as soon as possible.
The Augusta Chronicle ©2013. All Rights Reserved.